KDM4B and pancreatic ductal adenocarcinoma: As shown in Figure 7A, high KDM4B expression was coupled with a good prognosis of overall survival (OS) for patients with BRCA, LIHC, pancreatic ductal adenocarcinoma, HNSC, and UCEC within the pan‐cancer RNA‐seq project (Figure 7A, p < 0.05).